» Articles » PMID: 9595975

Histopathologic Correlate of Hypointense Lesions on T1-weighted Spin-echo MRI in Multiple Sclerosis

Overview
Journal Neurology
Specialty Neurology
Date 1998 May 22
PMID 9595975
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

Postmortem unfixed whole brains from five multiple sclerosis (MS) patients were examined by MRI using a T2- and T1-weighted spin-echo (SE) sequence and histology to investigate the histopathologic characteristics of hypointense lesions on T1-weighted SE MR images. The degree of hypointensity was scored semiquantitatively by two blinded observers in reference to normal-appearing white matter. Signal intensities of the lesions and the normal-appearing white matter were measured to obtain contrast ratios. Hematoxylin-eosin stain was used to assess degree of matrix destruction (decrease of density of the neuropil) and cellularity of a lesion, Klüver-Barrera stain for degree of demyelination, Bodian stain for axonal density, and immunostaining of glial fibrillary acid protein for reactive astrocytes and fibrillary gliosis. Nineteen lesions were selected for analysis. Nearly all lesions were compatible with the chronic MS plaque: hypocellularity, absence of myelinated axons, in the presence of reactive astrocytes. Contrast ratios of the lesions were highly correlated (R = -0.90; p < 0.01), with degree of hypointensity scored semiquantitatively. Degree of hypointensity on T1-weighted SE images did not correlate with degree of demyelination or number of reactive astrocytes, but was associated with axonal density (R = -0.71; p = 0.001). A trend was found with degree of matrix destruction (R = 0.45; p = 0.052). We conclude that, in our limited sample, hypointense lesions seen on T1-weighted SE MR images are associated histopathologically with severe tissue destruction, including axonal loss. Our results need to be substantiated in a larger study on more varied patient material to evaluate the use of hypointense lesions as a surrogate marker of persistent deficit in MS patients.

Citing Articles

Machine learning for refining interpretation of magnetic resonance imaging scans in the management of multiple sclerosis: a narrative review.

Szekely-Kohn A, Castellani M, M Espino D, Baronti L, Ahmed Z, Manifold W R Soc Open Sci. 2025; 12(1):241052.

PMID: 39845718 PMC: 11750376. DOI: 10.1098/rsos.241052.


Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.

Rocca M, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N Lancet Reg Health Eur. 2024; 44:100978.

PMID: 39444702 PMC: 11496980. DOI: 10.1016/j.lanepe.2024.100978.


Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" study.

Filippi M, Pagani E, Turrini R, Bartezaghi M, Morra V, Borriello G J Neurol. 2024; 271(9):6181-6196.

PMID: 39073436 DOI: 10.1007/s00415-024-12590-z.


Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis.

Ravano V, Andelova M, Piredda G, Sommer S, Caneschi S, Roccaro L J Neurol. 2024; 271(9):5944-5957.

PMID: 39003428 PMC: 11377637. DOI: 10.1007/s00415-024-12568-x.


The impact of image contrast, resolution and reader expertise on black hole identification in Multiple Sclerosis.

Tranfa M, Scaravilli A, Pastore C, Montella A, Lanzillo R, Kimura M Neuroradiology. 2024; 66(8):1345-1352.

PMID: 38374410 DOI: 10.1007/s00234-024-03310-5.